Alliancebernstein L.P. Apellis Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 31,929 shares of APLS stock, worth $660,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,929

Previous 44,912 28.91%

Holding current value

$660,611

Previous $982,000 43.79%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$16.36 - $23.0 $212,401 - $298,609	-12,983 Reduced 28.91%	31,929 $552,000
Q1 2025 May 15, 2025	BUY	$21.87 - $34.63 $296,819 - $469,998	13,572 Added 43.31%	44,912 $982,000
Q4 2024 Feb 12, 2025	SELL	$26.18 - $35.42 $253,370 - $342,794	-9,678 Reduced 23.59%	31,340 $1 Million
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $265,212 - $378,415	9,196 Added 28.9%	41,018 $1.18 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $15,570 - $24,421	409 Added 1.3%	31,822 $1.22 Million
Q1 2024 May 14, 2024	BUY	$55.39 - $72.47 $47,469 - $62,106	857 Added 2.8%	31,413 $1.85 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $40,259 - $70,264	1,084 Added 3.68%	30,556 $1.83 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $3,192 - $12,044	-135 Reduced 0.46%	29,472 $1.12 Million
Q2 2023 Aug 15, 2023	SELL	$76.68 - $93.31 $6.25 Million - $7.6 Million	-81,493 Reduced 73.35%	29,607 $2.7 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $1.81 Million - $2.55 Million	-41,824 Reduced 27.35%	111,100 $5.74 Million
Q3 2022 Nov 15, 2022	SELL	$44.76 - $69.66 $515,500 - $802,274	-11,517 Reduced 7.0%	152,924 $10.4 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $499,011 - $842,499	-14,229 Reduced 7.96%	164,441 $7.44 Million
Q1 2022 May 13, 2022	BUY	$35.46 - $54.12 $3.5 Million - $5.34 Million	98,670 Added 123.34%	178,670 $9.08 Million
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $24,592 - $39,328	800 Added 1.01%	80,000 $3.78 Million
Q3 2021 Nov 10, 2021	SELL	$31.4 - $69.84 $28,260 - $62,856	-900 Reduced 1.12%	79,200 $2.61 Million
Q3 2020 Nov 12, 2020	SELL	$25.89 - $33.65 $41,424 - $53,840	-1,600 Reduced 1.96%	80,100 $2.42 Million
Q2 2020 Aug 13, 2020	BUY	$24.8 - $38.49 $161,200 - $250,185	6,500 Added 8.64%	81,700 $2.67 Million
Q1 2020 May 14, 2020	BUY	$17.91 - $44.33 $26,865 - $66,495	1,500 Added 2.04%	75,200 $2.02 Million
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $462,600 - $651,238	25,700 Added 53.54%	73,700 $1.87 Million
Q3 2018 Nov 08, 2018	SELL	$16.57 - $21.03 $902,120 - $1.14 Million	-54,443 Reduced 53.14%	48,000 $853,000
Q2 2018 Aug 13, 2018	BUY	$19.63 - $30.0 $2.01 Million - $3.07 Million	102,443 New	102,443 $2.25 Million
Q1 2018 May 14, 2018	SELL	$14.01 - $26.02 $1.19 Million - $2.21 Million	-85,000 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$12.71 - $21.7 $1.08 Million - $1.84 Million	85,000	85,000 $1.85 Million

Others Institutions Holding APLS

# of Institutions

302

Shares Held

134M

Call Options Held

2.97M

Put Options Held

623K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.27B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Apellis Pharmaceuticals, Inc. Transaction History